These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9005883)

  • 1. Do repolarization abnormalities in hypertrophic cardiomyopathy represent impaired fatty acid utilization? An observation with QRST isointegral maps.
    Kawakami Y; Shimada S; Sakai Y; Suwa M; Nagao H; Hirota Y; Kawamura K; Adachi I; Narabayashi I
    J Electrocardiol; 1997 Jan; 30(1):21-9. PubMed ID: 9005883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [QRST isointegral map in dilated cardiomyopathy].
    Kawakami Y; Sakai Y; Kawamura K
    Nihon Rinsho; 1995 Jan; 53(1):219-24. PubMed ID: 7897847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
    Narita M; Kurihara T; Usami M; Honda M
    Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
    Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
    J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body surface distribution of abnormally low QRST areas in patients with left ventricular hypertrophy. An index of repolarization abnormalities.
    Hirai M; Hayashi H; Ichihara Y; Adachi M; Kondo K; Suzuki A; Saito H
    Circulation; 1991 Oct; 84(4):1505-15. PubMed ID: 1833086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical analysis of myocardial perfusion and metabolism in patients with hypertrophic cardiomyopathy by single photon emission tomography and positron emission tomography.
    Ishida Y; Nagata S; Uehara T; Yasumura Y; Fukuchi K; Miyatake K
    J Cardiol; 2001; 37 Suppl 1():121-8. PubMed ID: 11433815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
    Miyanaga H; Kawasaki S; Yoneyama S; Hyougo T; Kamitani T; Takahashi T; Kunishige H
    Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
    Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
    J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial impairment detected by late gadolinium enhancement in hypertrophic cardiomyopathy: comparison with 99mTc-MIBI/tetrofosmin and 123I-BMIPP SPECT.
    Hashimura H; Kiso K; Yamada N; Kono A; Morita Y; Fukushima K; Higashi M; Noguchi T; Ishibashi-Ueda H; Naito H; Sugimura K
    Kobe J Med Sci; 2013 Jun; 59(3):E81-92. PubMed ID: 24045217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of regional wall motion and fatty acid metabolism in coronary artery disease, hypertension, and hypertrophic cardiomyopathy: assessment by dual-isotope SPECT with thallium-201 and iodine-123 beta-methyl fatty acid analogue].
    Hase M; Nakata T; Yonekura S; Tsuchihashi K; Kobayashi H; Nagao K; Tanaka S; Kubota M; Tsuda T; Iimura O
    Kaku Igaku; 1993 May; 30(5):529-39. PubMed ID: 8336412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation between thallium-201/iodine 123-BMIPP subtraction and fluorine 18 deoxyglucose polar maps in patients with hypertrophic cardiomyopathy.
    Ito Y; Hasegawa S; Yamaguchi H; Yoshioka J; Uehara T; Nishimura T
    J Nucl Cardiol; 2000; 7(1):16-22. PubMed ID: 10698230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPET.
    Chen SL; Uehara T; Morozumi T; Yamagami H; Kusuoka H; Nishimura T
    Nucl Med Commun; 1995 May; 16(5):336-43. PubMed ID: 7659385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy.
    Shimizu M; Yoshio H; Ino H; Taki J; Nakajima K; Bunko H; Takeda R
    Int J Cardiol; 1996 Apr; 54(1):51-9. PubMed ID: 8792185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
    Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H
    Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The characteristic feature of myocardial imaging with 123I-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy].
    Ohtsuki K; Sugihara H; Ito K; Matsumoto K; Taniguchi Y; Terada K; Nakagawa T; Shima T; Kuribayashi T; Ochiai M
    Kaku Igaku; 1995 Apr; 32(4):377-85. PubMed ID: 7776544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia.
    Matsuo S; Nakamura Y; Takahashi M; Mitsunami K; Kinoshita M
    Jpn Circ J; 1998 Mar; 62(3):167-72. PubMed ID: 9583441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP).
    Ohtsuki K; Sugihara H; Umamoto I; Nakamura T; Nakagawa T; Nakagawa M
    Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.
    Takeishi Y; Chiba J; Abe S; Tonooka I; Komatani A; Tomoike H
    Eur J Nucl Med; 1992; 19(9):775-82. PubMed ID: 1396872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy.
    Ohtsuki K; Sugihara H; Kuribayashi T; Nakagawa M
    J Nucl Med; 1999 Dec; 40(12):2007-13. PubMed ID: 10616878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial sympathetic activity and characteristics in hypertrophic cardiomyopathy: comparison with hypertensive hypertrophy].
    Narita M; Kurihara T
    J Cardiol; 1996 Mar; 27(3):133-41. PubMed ID: 8865685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.